Literature DB >> 22127550

Muscarinic acetylcholine receptor-mediated activation of G(q) in rat brain membranes determined by guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding using an anti-G protein scintillation proximity assay.

Yuji Odagaki1, Ryoichi Toyoshima.   

Abstract

In the present study, we performed antibody-capture guanosine-5'-O-(3-[(35)S]thio)triphosphate ([(35)S]GTPγS) scintillation proximity assay (SPA), in which immuno-capture of Gα subunits following [(35)S]GTPγS binding was combined with SPA technology, in rat brain membranes. Preliminary experiments using a series of agonists and commercially available anti-Gα antibodies indicated the increase in specific [(35)S]GTPγS binding to Gα(q) determined with the anti-Gα antibody sc-393 and evoked by carbamylcholine chloride (CCh) was pharmacologically relevant. The experimental conditions were optimized as for the concentrations of GDP, MgCl(2), and NaCl, the dilution of the anti-Gα(q) antibody, and membrane protein contents incubated. Under the optimized conditions, CCh-stimulated specific [(35)S]GTPγS binding to Gα(q) in a concentration-dependent and saturable manner with an EC(50) of around 10 μM in all of the membranes prepared from rat hippocampus, cerebral cortex, and striatum. The maximum responses were varied according to the brain regions, with the rank order in magnitude of hippocampus > cerebral cortex > striatum. The addition of MT-7, a snake toxin with high selectivity for M(1) over the other muscarinic acetylcholine receptors (mAChRs) (M(2)-M(5)), almost completely extinguished CCh-stimulated [(35)S]GTPγS binding to Gα(q), even at a concentration as low as 1 nM. These results indicate that the functional coupling between M(1) mAChR and Gα(q) can be investigated in rat native brain membranes by means of antibody-capture SPA/[(35)S]GTPγS binding assay. The assay developed in the present study would provide a useful strategy for investigation of possible pathophysiological alterations in neuropsychiatric disorders such as Alzheimer's disease and schizophrenia as well as for drug discovery. © Springer-Verlag 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127550     DOI: 10.1007/s00702-011-0742-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

Review 1.  The [35S]GTPgammaS binding assay: approaches and applications in pharmacology.

Authors:  C Harrison; J R Traynor
Journal:  Life Sci       Date:  2003-12-12       Impact factor: 5.037

2.  Detailed pharmacological characterization of 5-HT1A-receptor-mediated [35S]GTP gamma S binding in rat hippocampal membranes.

Authors:  Yuji Odagaki; Ryoichi Toyoshima
Journal:  J Pharmacol Sci       Date:  2005-05-12       Impact factor: 3.337

3.  5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.

Authors:  Yuji Odagaki; Ryoichi Toyoshima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-21       Impact factor: 3.000

4.  Scintillation proximity assay.

Authors:  Steven D Kahl; Christian C Felder
Journal:  Curr Protoc Neurosci       Date:  2005-02

Review 5.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

Authors:  M P Caulfield; N J Birdsall
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

6.  5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.

Authors:  Yuji Odagaki; Ryoichi Toyoshima
Journal:  Eur J Pharmacol       Date:  2005-09-21       Impact factor: 4.432

7.  Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Ryoichi Toyoshima
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-05-05       Impact factor: 4.080

8.  Native rat hippocampal 5-HT1A receptors show constitutive activity.

Authors:  Jean-Claude Martel; Anne-Marie Ormière; Nathalie Leduc; Marie-Bernadette Assié; Didier Cussac; Adrian Newman-Tancredi
Journal:  Mol Pharmacol       Date:  2006-12-13       Impact factor: 4.436

9.  Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue.

Authors:  Hasib Salah-Uddin; David R Thomas; Ceri H Davies; Jim J Hagan; Martyn D Wood; Jeannette M Watson; R A John Challiss
Journal:  J Pharmacol Exp Ther       Date:  2008-03-05       Impact factor: 4.030

Review 10.  Muscarinic acetylcholine receptors as CNS drug targets.

Authors:  Christopher J Langmead; Jeannette Watson; Charlie Reavill
Journal:  Pharmacol Ther       Date:  2007-12-20       Impact factor: 12.310

View more
  3 in total

1.  Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Ryoichi Toyoshima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-09       Impact factor: 3.000

2.  Functional activation of Gαq coupled to 5-HT2A receptor and M1 muscarinic acetylcholine receptor in postmortem human cortical membranes.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Toshio Ota; J Javier Meana; Luis F Callado; Jesús A García-Sevilla
Journal:  J Neural Transm (Vienna)       Date:  2017-07-07       Impact factor: 3.575

3.  Measuring substrate binding and affinity of purified membrane transport proteins using the scintillation proximity assay.

Authors:  Daniel Harder; Dimitrios Fotiadis
Journal:  Nat Protoc       Date:  2012-08-02       Impact factor: 13.491

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.